Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel

Area of Science:

• Neuroscience
• Immunology
• Endocrinology

Background:

• Microglial activation is central to Parkinson's disease (PD) pathogenesis.
• Age and male gender are established risk factors for PD.
• Gender-specific differences in microglial responses and dopaminergic neuron loss are observed.

Purpose of the Study:

• To investigate the role of ovarian hormones, specifically 17β-estradiol, in modulating age- and inflammation-induced microglial activation and dopaminergic neuron loss.
• To elucidate the underlying molecular mechanisms of estrogen's protective effects.

Main Methods:

• Comparative analysis of microglia and dopaminergic neurons in male and female mice of varying ages.
• Assessment of lipopolysaccharide (LPS)-induced responses.
• Ovariectomy (OVX) and 17β-estradiol supplementation in mice.
• In vitro studies using BV2 microglial cells to examine molecular pathways and ion channel activity.

Main Results:

• Microglial activation and dopaminergic neuron loss increased with age, more profoundly in males.
• Ovariectomy abolished female protection, implicating ovarian hormones.
• 17β-estradiol treatment reduced microglial activation in OVX mice and inhibited LPS-induced inflammatory markers (TLR4, p38, TNF-α) in BV2 cells.
• 17β-estradiol suppressed Kir2.1 channel activity in microglial cells.

Conclusions:

• Ovarian estrogen attenuates age- and inflammation-associated microglial activation.
• Estrogen exerts its protective effects by inhibiting the Kir2.1 channel in microglia.
• These findings highlight a potential therapeutic role for estrogen in mitigating PD progression, particularly in males.